ENTITY
Bloomage Biotechnology  Lt

Bloomage Biotechnology Lt (688363 CH)

65
Analysis
Health CareChina
Bloomage Biotechnology Corporation Limited develops and manufactures medical products. The Company produces fillers, mesotherapy products, bio reactive hyaluronic acids, repair soothing skin care products, and other products. Bloomage Biotechnology supplies its products in medicine, cosmetics, food manufacturing companies, medical institutions, and other fields.
more
Refresh

Pre-IPO Raily Aesthetic Medicine (2135.HK) - Here Are the Concerns

The article analyzed the major concerns of Raily Aesthetic Medicine in terms of financial position, high-quality talents, domestic regulations and...

Logo
583 Views
Share
19 Nov 2020 20:09

Yatsen IPO Trading - A Little More Pricey Now

Yatsen Holding raised around US$617m in its US IPO, by pricing its IPO at the top-end of its range. The company is backed by Hillhouse, Tencent and...

Logo
431 Views
Share
16 Nov 2020 16:41

Yatsen IPO - Pricey but It Comes with Strong Investor Backing

Yatsen Holding aims to raise around upto US$617m in its US IPO. The company is backed by Hillhouse, Tencent and Tiger Global.

Logo
298 Views
Share
x